Ingelvac PRRS ATP
®
PRRS Vaccine
Description
Ingelvac PRRS® ATP is a modifiedlive PRRS vaccine that is proven safe
in pigs and non-pregnant gilts and sows
in PRRS positive herds. It provides cross
protection against heterologous challenge
and has shown to signficantly reduce
reproductive failure and respiratory disease
due to PRRS virus.1,2,3
Features
• Developed from an isolated atypical
PRRS parent strain.
• Safe in pigs and non-pregnant gilts
or sows.
• Aids in the reduction of both
reproductive and respiratory forms of
the disease caused by PRRS virus.
• Proven cross-protection against
heterologous challenge.1,2,3
• Easy-to-use, cost effective and field
proven against reproductive and
respiratory forms of PRRS virus.
• Demonstrated 120-day duration of
immunity (DOI).
Benefits
Significantly reduces reproductive failure
due to PRRS.2
Demonstrated protection following
respiratory challenge with a highly
virulent heterologous PRRS virus.1,3
Significantly reduces PRRS induced
lung lesions.1,3
Advantages
Ingelvac PRRS ATP is a highly effective
modified live PRRS vaccine, with
demonstrated protection against
highly virulent heterologous strains
of PRRS virus.1,2
Controls both reproductive
and respiratory forms
of PRRS.
Dosage & Administration
Uses
Rehydrate the vaccine by adding the full
contents of the accompanying liquid
diluent to the vaccine vial. Shake well
and use immediately. Rehydrate only
with the diluent provided: do not mix with
other materials.
Recommended for the vaccination
of healthy, susceptible swine as an aid
in the reduction of disease associated
with Porcine Reproductive and
Respiratory Syndrome virus, reproductive
and respiratory forms. The duration of
immunity is at least 4 months or throughout
the gestation or finishing period.
Sows and Gilts: Using aseptic technique,
administer a single 2 mL dose intramuscularly at 3-4 weeks prior to breeding
for the reproductive form of the PRRS.
Piglets: Using aseptic technique, administer
a single 2 mL dose intramuscularly to swine
3 weeks of age or older for the respiratory
form of the disease. Administer the
complete 2 mL dose to each pig vaccinated.
Efficacy and safety of the vaccine at
other than the dose or route prescribed on
the label is unknown and therefore, not
recommended and not USDA approved.
Anaphylactoid reactions may occur.
Antidote: Epinephrine
Precautions
For veterinary use only, for use only in
swine in PRRS virus positive herds
as directed.
Highlights
• Modified live virus vaccine
with demonstrated heterologous
efficacy.1,2,3
• Significantly reduced PRRS
induced lung lesions.1,3
• Significantly reduced clinical
disease associated with the
reproductive and respiratory
forms of PRRS .
1. Data on file. Study Report No. 623-852-98P-129
2. Data on file. Study Report No. 623-852-98P-149
3. Data on file. Study Report No. 623-850-98P-013
Recommended for use in healthy pigs,
non-pregnant gilts or sows in PRRS virus
positive herds only, per label directions.
Do not vaccinate breeding age boars or
pregnant females.
Product Information
Name Code
Size
Ingelvac
PRRS® ATP
127-811
20 mL
10 doses
127-831
100 mL
50 doses
a temperature between 35-45°F
(2-7°C). Use entire contents when first
opened. Do not vaccinate within 21 days
before slaughter. Do not vaccinate pregnant
sows. Do not use in adult boars, sows, or gilts.
Burn containers and all unused contents.
Anaphylactoid reactions may occur.
Porcine Reproductive
and Respiratory
Syndrome Vaccine,
Antidote: Ephinephrine.
Respiratory Form,
Modified Live Virus
Preservative: Neomycin.
Ingelvac PRRS® ATP
Directions: Rehydrate the vaccine by
adding the accompanying liquid diluent to
the vaccine vial. Shake well and use immediately.
Boehringer Ingelheim Vetmedica, Inc.
St. Joseph, MO 64506
U.S. Veterinary License No. 124
Atypical Virus
50 Doses/Rehydrate with 100 mL
Code 127-831; 27802-00
Dosage: Using aseptic technique, administer a single 2 mL dose intramuscularly to
swine 3 weeks of age or older.
abcd
Precautions: Store out of direct sunlight at
o
pt
Le
us
Pa
r
5-
vo
Wa
y
vir
las
ipe
Ingelvac PRRS® ATP
✓
✓
Ingelvac PRRS® MLV
✓
✓
ReproCyc® PRRS PLE
✓
✓
✓
✓
✓
✓
✓
✓
ReproCyc® PLE
Re
Er
ys
od
pr
sp
ira
uc
tor
tiv
yP
eP
RR
S
RR
S
PRRS & Reproductive Tools
Re
Serial No.:
Exp. Date:
Indications: Recommmended for the vaccination of healthy, susceptible swine 3
weeks of age or older, up to 18 weeks of
age, as an aid in the reduction of disease
associated with atypical Porcine Reproductive and Respiratory Syndrome virus, respiratory form. The duration of immunity is
throughout the finishing period, or up to 4
months post-vaccination. For use only in
swine in PRRS virus positive herds as
directed.
Boehringer Ingelheim Vetmedica, Inc.
2621 North Belt Highway • St. Joseph, MO 64506-2002
Information 800-325-9167 • Sales Service 800-325-9167 • Fax 816-236-2717
www.bi-vetmedica.com
BI S127811-RP-20 8/12